Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Figure 1. lncRNA loci are recurrently mutated in patients with neurodevelopmental disorders. ; (A) Schematic representation of CNV morbidity map analysis for candidate lncRNAs and all other iN lncRNAs loci. The 35 mouse lncRNA candidates (28 human loci) is from Figure 1—figure supplement 1H. (B) Top: Representative tracks for lncRNA E locus, also known as lnc-NR2F1. Depicted in blue are deletions and in red duplications. Arrow points to patient with focal deletion affecting the lnc-NR2F1 locus only. Bottom: Custom CGH arrays used to validate chromosomal aberration in patient 9900850 harboring focal deletion represented in green signal. (C) Genetic pedigree analysis for family with paternally inherited balanced chromosomal translocation (5;12) (q15;q15), including a summary of clinical features for patient CMS12200 and father. The mother has a normal karyotype. Listed in the box are the symptoms of the patients. (D) Top: Circa plot representing the pathogenic chromosomal event for patient CMS12200 involving chromosomes 5 and 12. Bottom: Representative chromosome ideogram and track of the balanced chromosomal break affecting patient CMS12200. Below the ideoplot is the schematic representation of predominant human isoforms for lnc-NR2F1 and the site of the break site disrupting the long isoforms. (E) The locations of the probes are in Figure 1—figure supplement 4C. Left: Metaphase spread from patient CMS12200 with the t(5;12) translocation showing FISH signals obtained with the clone RP11-608G16 (green) spanning Chromosome five breakpoint, and a Chromosome five telomere-specific probe (red). Middle: Metaphase spread from patient CMS12200 with the t(5;12) translocation showing FISH signals obtained with the clone RP11-597C7(green) proximal to Chromosome 12 breakpoint, and a Chromosome 12 centromere-specific probe (red). Right: Metaphase spread from patient CMS12200 with the t(5;12) translocation showing FISH signals obtained with the clone RP11-641O3 (green) distal to Chromosome 12 breakpoint, and a Chromosome 12 centromere-specific probe (red).

Record details

×

Figure 1—figure supplement 3. Stable neuronal function and environment-specific activity. ; (A,B) Both ‘activity divergence’, the difference in event rate between trials in different environments relative to the difference in event rate between trials in the same environment (A), and ‘peak displacement’, the average distance between locations of peak activity in different environments (B), did not change over the course of the experiment (One-way repeated-measures ANOVA; F(1.9, 7.6) = 1.06, p = 0.39 and F(2.6, 10.5) = 1.22, p = 0.345 respectively). (C) Average number of Ca2+ events detected on different days of the experiment did not change with time (One-way repeated-measures; F(1.87, 7.49) = 1.19, p = 0.35). (D) Amplitudes of Ca2+ events remained similar over the course of the experiment (One-way repeated-measures; F(1.32, 5.29) = 3.29, p = 0.35.). (E) Fractions of place cells from the population of cells active in each environment were similar for both environments and did not change with time. Two-way repeated measures ANOVA between environment A and B (F < 1, p = 0.42), over time (F(2.32,9.30) = 1.99, p = 0.19), and environment X time interaction (F(1.93, 7.72) = 1.71, p = 0.243). Data are mean ± s.e.m. (F) Representative two-photon microendoscopy images of CA1 neurons performed before and after the experiment. The images revealed no increase in the number of cells with filled nuclei (a marker for GCaMP-induced neuronal morbidity). Scale bar is 50 μm.

Record details

×
  • 1-10 of  85 results for ""morbidity""